Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Home
General Information
GPI map
GPI Posters
Eligibility criteria
Submissions and guidelines
Poster Guidelines
Best GPI Award
You are here
Home
Map of Evidence
Search by
Fulltext search
Keywords
- Any -
Clinical pharmacy
-Acceptance rate
-Admission
-Antimicrobial stewardship
-Clinical pharmacy services
-Clinical practice
-Clinical trial medication
-Clinical trials
-Discharge management
-Discharge prescription
-Discontinuation of therapy
-Drug reconcilliation
-Drug related problem
-Drug review
-Ethics committee
-General practitioners
-Healthcare team
-Health-related quality of life
-Impact clinical pharmcacy
-Interventions
-Medication error
-Medication history
-Medication reconciliation
-Medication review
-Medication-use system
-Medicines optimisation
-Monitoring
-Mortality
-Multidisciplinary
-Multidisciplinary team
-Patient acceptance
-Patient counselling
-Patient discharge
-Patient empowerment
-Patient feedback
-Patient involvement
-Patient perspectives
-Patient satisfaction
-Pharmaceutical care
-Pharmacy interventions (pi)
-Polymedication
-Polypharmacy
-Polytherapy
-Primary care
-Reconciliation
-Seamless care
-Shared decision making
-Stopp/start
Drug group
-Generics
-Herbal medicine
-High risk medication
-Orphan drugs
-Over the counter medicines
-A02 - drugs for acid related disorders
-A03 - drugs for functional gastrointestinal disorders
-A04 - antiemetics and antinauseants
-A05 - bile and liver therapy
-A06 - laxatives
-A07 - antidiarrheals, intestinal antiinflammatory/antiinfective agents
-A08 - antiobesity preparations, excluding diet products
-A10 - drugs used in diabetes
-A11 - vitamins
-A16 - other alimentary tract and metabolism products
-B01 - antithrombotic agents
-B02 - antihemorrhagics
-B03 - antianemic preparations
-B05 - plasma substitutes and perfusion solutions
-B06 - other hematological agents
-C01 - cardiac therapy
-C02 - antihypertensives
-C03 - diuretics
-C04 - peripheral vasodilators
-C07 - beta blocking agents
-C08 - calcium channel blockers
-C09 - agents acting on the renin-angiotensin system
-C10 - lipid modifying agents
-D01 - antifungals for dermatological use
-D02 - emollients and protectives
-D03 - preparations for treatment of wounds & ulcers
-D05 - antipsoriatics
-D06 - antibiotics and chemotherapeutics for dermatological use
-D10 - anti-acne preparations
-D11 - other dermatological preparations
-G02 - other gynecologicals
-G03 - sex hormones and modulators of the genital system
-G04 - urologicals
-H01 - pituitary and hypothalamic hormones
-H02 - corticosteroids for systemic use
-H05 - calcium homeostasis
-J01 - antibacterials for systemic use
-J02 - antimycotics for systemic use
-J04 - antimycobacterials
-J05 - antivirals for systemic use
-J06 - immune sera and immunoglobulins
-J07 - vaccines
-L01 - cytostatics
-L02 - endocrine therapy
-L03 - immunomodulating agents
-L04 - immunosuppressive agents
-M01 - antiinflammatory and antirheumatic products
-M03 - muscle relaxants
-M04 - antigout preparations
-M05 - drugs for treatment of bone diseases
-M09 - other drugs for disorders of the musculo-skeletal system
-N01 - anesthetics
-N02 - analgesics
-N03 - antiepileptics
-N04 - anti-parkinson drugs
-N05 - psycholeptics
-N06 - psychoanaleptics
-N07 - other nervous system drugs
-P01 - antiprotozoals
-R01 - nasal preparations
-R03 - anti-asthmatics
-R05 - cough and cold preparations
-R06 - antihistamines for systemic use
-R07 - other respiratory system products
-S01 - ophthalmologicals
-V03 - all other therapeutic products
-V04 - diagnostic agents
-V08 - contrast media
-V09 - diagnostic radiopharmaceuticals
-V10 - therapeutic radiopharmaceuticals
Drug administration
-Administration
-Co-medication
-Enteral
-Enteral feeding
-Enteral nutrition
-Intravenous to oral switch
-Injection
-Nasogastric tube
-Oral medication
-Partial tablets
-Patient self administration
-Ready to administer
-Ready to use
-Self-administration
-Single dose
-Skin permeation
-Tablet breaking
Drug dispensing
-Dispensing
-Dispensing drugs
-Dispensing errors
-Dispensing forms
-Dispensing robots
-Electronic drug cabinets
-Multi dose blister-packaging
-Multidose
-Robotic dispensing system
-Unitdose
Drug distribution and supply
-Automated dispensing cabinets
-Automated dispensing system
-Bar code
-Barcode verification
-Control of the delivery
-Controlled drugs
-Delivery performance
-Drug packaging
-Drug recall
-Drug shortage
-Drug stability
-Drug storage
-Forecasting
-Multi dose blister-packaging
-Multidose drugs
-One-stop dispensing
-Stock control
-Storage conditions
-Storage systems
-Suppliers
-Supply chain
-Temperature log
-Unit-dose drug distribution
Drug information
-Databases
-Evidence based medicine
-Patient education
-Patient empowerment
-Patient information
-Pharmaceutical counseling
-Telemedicine
-Therapeutic education of patients
Drug safety
-Adverse drug events
-Adverse drug reaction
-Allergy
-Drug safety
-Drug dosage errors
-Drug interaction
-Hypersensitivity reactions
-Overdose
-Pharmacovigilance
-Pharmacovigilance system
-Poisoning
-Response rate
-Safety profile
-Side effects
-Skin tests
-Tolerability
-Toxicity
-Treatment failure
Drug selection
-Drug and therapeutic committee
-Drug formulary management
-Drug selection
-Evidence based medicine
-Indications
-Off-label indication
-Optimisation of therapy
-Recommendation
-Restricted use
-Selection of drugs
-Substitution
Drug prescribing and dosing
-Antimicrobial prescribing
-Antimicrobial stewardship
-Co-medication
-Complementary medicine
-Computer assisted prescribing (cpoe)
-Computerized physician order entry (cpoe)
-Decision aid
-Discontinuation of therapy
-Dosage
-Dosage calculation
-Dose adjustment
-Dose banding
-Dose intensity
-Dose optimization
-Dose reduction
-Drug dosing adjustment
-Drug interaction
-Drug substitution
-Electronic prescribing
-Inappropriate prescribing
-Independent nurse prescribers
-Indications
-Off-label prescribing
-Optimisation of therapy
-Pharmacist prescribing
-Polymedication
-Polypharmacy
-Polytherapy
-Prescribing errors
-Prescription appropriateness
-Prescription compliance
-Prescription validation
-Substitution
-Treatment discontinuation
-Treatment duration
Drug use
-Adherence
-Antibiotic resistance
-Antimicrobial resistance
-Compliance
-Consumption
-Medication discrepancy
-Non-adherence
Drug use evaluation
-Cost
-Cost analysis
-Cost effectiveness
-Cost minimization
-Cost saving
-Cost-benefit
-Cost-effectiveness
-Drug efficacy
-Drug prescribing pattern
-Drug pricing
-Drug reimbursement
-Drug therapy outcomes
-Drug use evaluation
-Follow-up study
-Off-label use
-Outcomes
-Pharmacoeconomics
-Pharmacoepidemiology
Education and research
-Competency assessment
-Competency evaluation
-Distance learning
-Education
-Educational program
-Educational tools
-E-learning
-Epidemiological investigation
-Ethics
-Evidence based medicine
-Follow-up study
-Guidelines impact
-Health-related quality of life
-Hospital pharmacy competencies
-Hospital pharmacy education
-Impact
-Interventions
-Interview
-Life long learning
-Outcomes
-Patient feedback
-Pcne classification
-Pharmacy interventions (pi)
-Pilot study
-Prevalence
-Qualitative reseacrh
-Quantitative research
-Research methodology
-Research
-Simulation
-Survey
-Training
Hospital setting
-Accident and emergency
-Admission
-Ambulatory
-Critical care
-Discharge
-Hospital care
-Hospital-home transition
-Icu
-Multidisciplinary team
-Nursing home
-Secondary care
IT
-Electronic communication
-Electronic documentation
-Electronic medication record
-Electronic patient record
-Electronic prescribing system
-Erp systems
-Information technology
-Information transmission
-It
-Medical apps
-Robots
-Telemedicine
Management
-Administration
-Benchmarking
-Big data
-Budget impact
-Business case
-Business plan
-Cost avoidance
-Cost control
-Delivery performance
-Drug reimbursement
-Financial management
-Health economics
-Health information management
-Health policy
-Healthcare team
-Human resource management
-International health services
-Job description
-Kpi
-Leadership
-Lean
-Length of hospital stay
-Management
-Nurses
-Oncology pharmacy
-Organisation of health services
-Organisational development
-Outpatient clinics
-Outpatient pharmacy
-Performance indicators
-Pharmacy design
-Project management
-Recruitment
-Shared decision making
-Staff satisfaction
-Staffing
-Technology implementation
-Time management
-Waste
Medical device
-Medical device
-Medical device viglance
Medical gas
-Medical gas
Patient characteristics
-Adolescent
-Children
-Chronic patient
-Comorbidities
-Elderly patients
-Ethnicity
-Geriatric patients
-Guidelines impact
-Health literacy
-Inpatient
-Neonate
-Obesity
-Outpatient
-Pediatric patients
-Pediatris
-Pregnancy
-Reduced liver function
Patient safety
-Computerized medical record
-Contraindicated
-Error-avoiding strategies
-Errors
-Failure modes and effects analysis
-High risk medication
-Look-alike
-Medication error
-Patient safety
-Root cause analysis
-Sound-alike
Pharmacokinetics og -dynamics
-Body mass index
-Body size
-Body surface area
-Contraindications
-Cumulative dose
-Cytochrome p450
-Drug distribution
-Drug metabolism
-Drug-drug interaction
-Drug-food interaction
-Intolerance
-Pharmacokinetic
-Pharmacodynamic
-Therapeutic drug monitoring (tdm)
-Therapeutic equivalence
-Therapeutic index
-Tolerance
-Toxicity
Preparation and compounding
-Active ingredient
-Aseptic preparation
-Autoclaves
-Automated production
-Closed system transfer device
-Compounding
-Compounding robots
-Contamination
-Cytostatic exposure
-Cytostatic preparations
-Dosing accuracy
-Drug formulation
-Drug stability
-Environmental contamination
-Excipients
-Exposition
-Ex-temporous drugs
-Facilities
-Individualised preparation
-Labelling
-Laminar air flow
-Large scale production
-Manufacturing
-Microbiological contamination
-Needlestick injuries
-Preparation
-Product information
-Production file
-Reconstitution
-Safety cabinets
-Small scale production
-Sterile compounding
-Sterile preparation
-Sterile production
-Wipe sampling
Procurement and market acess
-Drug procurement
-Contracts
-Generics
-Managed drug entry
-Market access
-Medicine prices
-Parallel import
-Procurement
-Provider assessment
-Risk sharing contracts
-Suppliers
-Tendering
-Tenders
Theraputic areas
-Acne
-Anemia
-Antiretroviral therapy
-Antithrombotic therapy
-Biologic therapy
-Cancer
-Cardiology
-Chemotherapy
-Constipation
-Dermatology
-Diabetes
-Eczema
-Endocrineology
-Gastroenterology
-Gene therapy
-Gynaecology
-Haematology
-Heart failure
-Hepatitis
-Hepatology
-Hiv & aids
-Immunology
-Infection diseases
-Infertility
-Intensive & critical care
-Internal medicine
-Medicine
-Oncology
-Ophthalmology
-Otolaryngology
-Pain management
-Palliative care
-Parasitology
-Pathology
-Pediatric medicine
-Perinatology
-Preventive medicine
-Psychiatry
-Pulmonology
-Radiology & imaging
-Radiotherapy
-Reproductive medicine
-Respiratory medicine
-Rheumatology
-Sexual medicine
-Sleep medicine
-Special patient groups
-Stroke medicine
-Surgical prophylaxis
-Toxicology
-Urology
-Virology
QC/QA
-Accuracy
-Change control
-Change management
-Change validation
-Chemical stability
-Compatibility
-Compliance
-Contamination
-Corrective actions
-Drug recall
-Gas chromatography (gc)
-Good distribution practice (gdp)
-Good laboratory practice (glp)
-Good manufacturing practice (gmp)
-Gravimetric control
-Hplc
-Ich-gcp
-Long term stability
-Micribiological testing
-Physical stability
-Quality assurance
-Quality control
-Shelf life
-Stability
-Sterility testning
-Temperature log
-Test for sterility (tfs)
-Traceability
-Uniformity of content
-Validation
Quality
-Acceptance rate
-Accreditation
-Audit
-Big data
-Computerized medical record
-Corrective actions
-Documentation system
-Error-avoiding strategies
-Errors
-Failure modes and effects analysis
-Feedback
-Guidelines
-Guidelines impact
-Improvement action
-Internal audit
-National standards
-Patient feedback
-Process improvement
-Protocols & guidelines
-Quality improvement
-Quality indicators
-Quality management system
-Quality monitoring
-Quality performance
-Quality standards
-Quality systems
-Reporting-program
-Risk
-Risk analysis
-Risk assessment
-Risk factor
-Risk management
-Risk mapping
-Risk matrix
-Risk minimization
-Risk-adjustment
-Root cause analysis
-Quality
Title
Statement
- Any -
Introductory Statements and Governance
Selection, Procurement and Distribution
Production and Compounding
Clinical Pharmacy Services
Patient Safety and Quality Assurance
Education and Research
Country
- Any -
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo (Brazzaville)
Congo (Kinshasa)
Cook Islands
Costa Rica
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Honduras
Hong Kong S.A.R., China
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Ivory Coast
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao S.A.R., China
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
North Korea
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Vatican
Venezuela
Vietnam
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Introductory Statements and Governance
Selection, Procurement and Distribution
Production and Compounding
Clinical Pharmacy Services
Patient Safety and Quality Assurance
Education and Research
Follow Us